MEDP logo

Medpace Holdings (MEDP) EBITDA

Annual EBITDA

$363.15 M
+$62.12 M+20.63%

December 31, 2023

Summary

Performance

1-Year Change

+20.63%

3-Year Change

+94.65%

5-Year Change

+159.68%

15-Year Change

+227.23%

MEDP EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.47%
MEDP annual EBITDA is higher than 91.47% of companies in Healthcare sector

High & Low

All-time High

$363.15 M
MEDP annual EBITDA is currently at an all-time high

3-Year Low

$219.73 M
MEDP annual EBITDA is currently +65.27% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MEDP previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 10, 2025
MEDP next annual earnings announcement is scheduled for Feb 10, 2025

OtherMEDPprofitabilitymetrics:

Annual Revenue

$1.89 B
MEDP annual revenue is $1.89 billion

Annual Net Income

$282.81 M
MEDP annual net profit is $282.81 million

Annual EBIT

$336.82 M
MEDP annual earnings before interest & taxes is $336.82 million

Annual EPS

$8.88
MEDP annual earnings per share is $8.88

Quarterly EBITDA

$119.79 M
+$7.41 M+6.59%

September 30, 2024

Summary

Performance

3-Month Change

+6.59%

1-Year Change

+6.59%

3-Year Change

+99.28%

5-Year Change

+241.79%

MEDP Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.02%
MEDP quarterly EBITDA is higher than 91.02% of companies in Healthcare sector

High & Low

All-time High

$119.79 M
MEDP quarterly EBITDA is currently at an all-time high

3-Year Low

$58.07 M
MEDP quarterly EBITDA is currently +106.30% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MEDP previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
MEDP next earnings announcement is scheduled for Feb 10, 2025

OtherMEDPprofitabilitymetrics:

Quarterly Revenue

$533.32 M
MEDP quarterly revenue is $533.32 million

Quarterly Net Income

$96.43 M
MEDP quarterly net profit is $96.43 million

Quarterly EBIT

$112.27 M
MEDP quarterly earnings before interest & taxes is $112.27 million

Quarterly EPS

$3.01
MEDP quarterly earnings per share is $3.01

TTM EBITDA

$437.53 M
+$28.00 M+6.84%

September 30, 2024

Summary

Performance

3-Month Change

+6.84%

1-Year Change

+6.84%

3-Year Change

+97.79%

5-Year Change

+190.81%

MEDP TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.69%
MEDP TTM EBITDA is higher than 91.69% of companies in Healthcare sector

High & Low

All-time High

$437.53 M
MEDP TTM EBITDA is currently at an all-time high

3-Year Low

$218.81 M
MEDP TTM EBITDA is currently +99.96% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MEDP previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
MEDP next earnings announcement is scheduled for Feb 10, 2025

OtherMEDPprofitabilitymetrics:

TTM Revenue

$2.07 B
MEDP TTM revenue is $2.07 billion

TTM Net Income

$365.67 M
MEDP TTM net profit is $365.67 million

TTM EBIT

$408.81 M
MEDP TTM earnings before interest & taxes is $408.81 million

TTM EPS

$11.42
MEDP TTM earnings per share is $11.42

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$363.15 M
MEDP annual EBITDA is $363.15 million

Annual Net Income

$282.81 M
MEDP annual net profit is $282.81 million

Annual Interest Expense

-
MEDP annual interest expense value is unknown

Annual Income Tax

$52.87 M
MEDP annual income tax is $52.87 million

Annual D&A

$26.33 M
MEDP annual depreciation & amortization is $26.33 million

MEDP EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.6%+6.6%+6.8%
3 y3 years+94.7%+99.3%+97.8%
5 y5 years+159.7%+241.8%+190.8%

MEDP EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+65.3%at high+106.3%at high+100.0%
5 y5-yearat high+141.4%at high+244.4%at high+190.8%
alltimeall timeat high+314.3%at high+1088.3%at high+4240.1%

Medpace Holdings EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$119.79 M(+6.6%)
$437.53 M(+6.8%)
Jun 2024
-
$112.39 M(+1.2%)
$409.52 M(+7.2%)
Mar 2024
-
$111.06 M(+17.8%)
$382.05 M(+5.2%)
Dec 2023
$363.15 M(+20.6%)
$94.29 M(+2.7%)
$363.15 M(+6.1%)
Sep 2023
-
$91.79 M(+8.1%)
$342.16 M(+0.7%)
Jun 2023
-
$84.91 M(-7.9%)
$339.64 M(+5.2%)
Mar 2023
-
$92.16 M(+25.7%)
$322.82 M(+7.6%)
Dec 2022
$301.04 M(+37.0%)
$73.30 M(-17.9%)
$299.97 M(+5.4%)
Sep 2022
-
$89.27 M(+31.1%)
$284.74 M(+11.4%)
Jun 2022
-
$68.09 M(-1.8%)
$255.58 M(+8.6%)
Mar 2022
-
$69.31 M(+19.4%)
$235.43 M(+7.6%)
Dec 2021
$219.73 M(+17.8%)
$58.07 M(-3.4%)
$218.81 M(-1.1%)
Sep 2021
-
$60.11 M(+25.4%)
$221.21 M(+4.1%)
Jun 2021
-
$47.94 M(-9.0%)
$212.47 M(+6.6%)
Mar 2021
-
$52.69 M(-12.9%)
$199.31 M(+6.8%)
Dec 2020
$186.57 M(+24.0%)
$60.47 M(+17.7%)
$186.57 M(+11.4%)
Sep 2020
-
$51.36 M(+47.7%)
$167.54 M(+10.8%)
Jun 2020
-
$34.78 M(-12.9%)
$151.22 M(-3.5%)
Mar 2020
-
$39.95 M(-3.6%)
$156.68 M(+4.1%)
Dec 2019
$150.45 M
$41.44 M(+18.2%)
$150.45 M(+1.2%)
DateAnnualQuarterlyTTM
Sep 2019
-
$35.05 M(-12.9%)
$148.62 M(-1.4%)
Jun 2019
-
$40.24 M(+19.3%)
$150.71 M(+4.7%)
Mar 2019
-
$33.73 M(-14.8%)
$143.91 M(+2.9%)
Dec 2018
$139.85 M(+26.0%)
$39.61 M(+6.7%)
$139.85 M(+9.6%)
Sep 2018
-
$37.13 M(+11.0%)
$127.57 M(+7.0%)
Jun 2018
-
$33.44 M(+12.7%)
$119.22 M(+5.0%)
Mar 2018
-
$29.67 M(+8.6%)
$113.50 M(+2.3%)
Dec 2017
$110.98 M(+11.6%)
$27.32 M(-5.1%)
$110.98 M(+9.5%)
Sep 2017
-
$28.79 M(+3.9%)
$101.34 M(+2.0%)
Jun 2017
-
$27.72 M(+2.1%)
$99.38 M(-0.9%)
Mar 2017
-
$27.15 M(+53.5%)
$100.23 M(+0.8%)
Dec 2016
$99.45 M(+11.8%)
$17.69 M(-34.1%)
$99.45 M(+4.2%)
Sep 2016
-
$26.82 M(-6.1%)
$95.45 M(+2.4%)
Jun 2016
-
$28.57 M(+8.3%)
$93.26 M(+2.3%)
Mar 2016
-
$26.38 M(+92.7%)
$91.14 M(+2.5%)
Dec 2015
$88.95 M(+1.5%)
$13.69 M(-44.4%)
$88.95 M(+18.2%)
Sep 2015
-
$24.63 M(-6.9%)
$75.26 M(+48.6%)
Jun 2015
-
$26.44 M(+9.3%)
$50.63 M(+109.3%)
Mar 2015
-
$24.19 M(+139.9%)
$24.19 M(+139.9%)
Mar 2014
-
$10.08 M
$10.08 M
Dec 2013
$87.66 M
-
-

FAQ

  • What is Medpace Holdings annual EBITDA?
  • What is the all time high annual EBITDA for Medpace Holdings?
  • What is Medpace Holdings annual EBITDA year-on-year change?
  • What is Medpace Holdings quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Medpace Holdings?
  • What is Medpace Holdings quarterly EBITDA year-on-year change?
  • What is Medpace Holdings TTM EBITDA?
  • What is the all time high TTM EBITDA for Medpace Holdings?
  • What is Medpace Holdings TTM EBITDA year-on-year change?

What is Medpace Holdings annual EBITDA?

The current annual EBITDA of MEDP is $363.15 M

What is the all time high annual EBITDA for Medpace Holdings?

Medpace Holdings all-time high annual EBITDA is $363.15 M

What is Medpace Holdings annual EBITDA year-on-year change?

Over the past year, MEDP annual EBITDA has changed by +$62.12 M (+20.63%)

What is Medpace Holdings quarterly EBITDA?

The current quarterly EBITDA of MEDP is $119.79 M

What is the all time high quarterly EBITDA for Medpace Holdings?

Medpace Holdings all-time high quarterly EBITDA is $119.79 M

What is Medpace Holdings quarterly EBITDA year-on-year change?

Over the past year, MEDP quarterly EBITDA has changed by +$7.41 M (+6.59%)

What is Medpace Holdings TTM EBITDA?

The current TTM EBITDA of MEDP is $437.53 M

What is the all time high TTM EBITDA for Medpace Holdings?

Medpace Holdings all-time high TTM EBITDA is $437.53 M

What is Medpace Holdings TTM EBITDA year-on-year change?

Over the past year, MEDP TTM EBITDA has changed by +$28.00 M (+6.84%)